{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:23:28Z","timestamp":1784773408959,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.dld.2020.07.029","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T01:51:49Z","timestamp":1597974709000},"page":"1167-1170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost of illness of Primary Biliary Cholangitis - a population-based study"],"prefix":"10.1016","volume":"53","author":[{"given":"Alessio","family":"Gerussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Restelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2020.07.029_bib0001","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep4.1407","article-title":"A national hospital-based study of hospitalized patients with Primary Biliary Cholangitis","volume":"3","author":"Manno","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2020.07.029_bib0002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.06.015","article-title":"The limitations and hidden gems of the epidemiology of primary biliary cirrhosis","volume":"46","author":"Podda","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2020.07.029_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2018.11.008","article-title":"Epidemiology of primary biliary cholangitis in Italy: evidence from a real-world database","author":"Marzioni","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2020.07.029_bib0004","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.07.029_bib0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep4.1314","article-title":"Burden of Primary Biliary Cholangitis among inpatient population in the United States","volume":"3","author":"Shahab","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2020.07.029_bib0006","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","author":"Harms","year":"2019","journal-title":"Alim Pharmacol Ther"},{"key":"10.1016\/j.dld.2020.07.029_bib0007","first-page":"167","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"145","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.07.029_bib0008","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in Primary Biliary Cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2020.07.029_bib0009","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in Primary Biliary Cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2020.07.029_bib0010","article-title":"Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies","author":"Gerussi","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2020.07.029_bib0011","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/00365521.2019.1669702","article-title":"Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy","volume":"54","author":"Vespasiani-Gentilucci","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2020.07.029_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40273-015-0325-4","article-title":"Cost-of-illness studies: an updated review of current methods","volume":"34","author":"Onukwugha","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.dld.2020.07.029_bib0013","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00019053-200624090-00005","article-title":"Cost-of-illness studies","volume":"24","author":"Akobundu","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.dld.2020.07.029_bib0014","unstructured":"Italian National Institute of Statistics. Resident population database n.d. http:\/\/dati.istat.it\/Index.aspx?QueryId=18460."},{"key":"10.1016\/j.dld.2020.07.029_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of Primary Biliary Cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2020.07.029_bib0016","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/apt.15095","article-title":"Editorial: liver transplantation for primary biliary cholangitis\u2013the need for timely and more effective treatments","volume":"49","author":"Gerussi","year":"2019","journal-title":"Alim Pharmacol Ther"},{"key":"10.1016\/j.dld.2020.07.029_bib0017","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.07.029_bib0018","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/liv.13353","article-title":"Treatment of PBC\u2014a step forward","volume":"37","author":"Carbone","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2020.07.029_bib0019","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.28932","article-title":"Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis","volume":"65","author":"Samur","year":"2017","journal-title":"Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582030387X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582030387X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:16:22Z","timestamp":1761624982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582030387X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S159086582030387X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2020.07.029","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost of illness of Primary Biliary Cholangitis - a population-based study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2020.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}